Sharp re-rating has turned the stock into the most expensive in the pharma space
from Latest News https://ift.tt/3n4FQ6A
Sunday, 3 January 2021
Limited near term gains for Syngene International stock in pharma space
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment